DEVELOPMENTS IN FIBRINOLYTIC THERAPY FOR THROMBO-EMBOLIC DISEASE
- 1 March 1959
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 50 (3) , 560-570
- https://doi.org/10.7326/0003-4819-50-3-560
Abstract
Studies are described concerning the mechanism by which thrombi are lysed, as well as the application of this information for the production of a controlled fibrinolytic state in the circulation of man. The current status of these studies as they relate to the therapy of thrombo-embolic disease in man is reviewed.Keywords
This publication has 7 references indexed in Scilit:
- Intravenous Protein-Free PyrogenCirculation, 1958
- THE USE OF PLASMIN IN HUMANSAnnals of the New York Academy of Sciences, 1957
- CLINICAL AND EXPERIMENTAL STUDIES ON FIBRINOLYTIC ENZYMESAnnals of the New York Academy of Sciences, 1957
- Prevention of Postoperative Adhesions in the Dog by Intravenous Injections of Plasminogen Activators.Experimental Biology and Medicine, 1955
- THE INTRAVENOUS INFUSION OF THE STREPTOCOCCAL FIBRINOLYTIC PRINCIPLE (STREPTOKINASE) INTO PATIENTS 1Journal of Clinical Investigation, 1955
- The Enzymatic Dissolution Of Experimental Arterial Thrombi in the Dog by Trypsin, Chymotrypsin and Plasminogen Activators12Journal of Clinical Investigation, 1954
- THE LYSIS IN RABBITS OF INTRAVASCULAR BLOOD CLOTS BY THE STREPTOCOCCAL FIBRINOLYTIC SYSTEM (STREPTOKINASE)The Journal of Experimental Medicine, 1952